multiple endocrine neoplasia 2

mul·ti·ple en·do·crine ne·o·pla·si·a 2

(MEN2) (mŭl'ti-pĕl en'dō-krin nē-ō-plā'zē-ă)
Syndrome associated with pheochromocytoma, parathyroid adenoma, and medullary thyroid carcinoma; autosomal dominant inheritance, caused by mutation in the RET oncogene on chromosome 10q.
References in periodicals archive ?
Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new millenium.
Distribution of RET mutations according to final diagnosis Diagnosis Cys634Arg Cys634Tyr Val804Met Cys618Ser Tyr791Phe MEN2A 9 2 1 2 1 FMTC 2 - 11 - - Mutation carrier 4 5 3 - 1 Diagnosis Y790Phe D631Y MEN2A - - FMTC 1 - Mutation carrier 2 1 MEN2A: multiple endocrine neoplasia 2 A, FMTC: familial medullary thyroid cancer Table 4.

Medical browser ?
Full browser ?